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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYInduced pluripotent stem cells (iPSCs) generated from somatic cells by ectopic expression of reprogramming factors, e.g., POU5F1
(OCT4), KLF4, and SOX2, have great potential for regenerativemedicine. However, before they can be used in a clinical setting, themech-
anism of reprogramming needs to be better understood. Here, by engineering reprogramming factors to a destabilizing protein domain,
we achieved inducible generation of mouse and pig iPSCs. Stability of the fusion protein was precisely regulated by the addition of the
cell-permeable small molecule trimethoprim (TMP) in a dose-dependent manner. With these tools, we found that during the early and
middle stages of reprogramming, exogenous OCT4 or KLF4 could be omitted, whereas exogenous SOX2 expression at early and middle
stages was required for successful reprogramming. Our TMP reprogramming system is useful for defining the stoichiometry and temporal
requirements of transcription factors for reprogramming.INTRODUCTION
Mouse and human somatic cells can be reprogrammed to
embryonic stem cell (ESC)-like cells, known as induced
pluripotent stem cells (iPSCs), classically by ectopic expres-
sion of transcription factors, Oct4, Klf4, Sox2, and c-Myc
(Okita et al., 2007; Takahashi and Yamanaka, 2006), or by
other combinations (Nakagawa et al., 2008; Wernig et al.,
2008b). The Cre/loxP and the Doxycycline (Dox)-inducible
systems have proven useful for studying reprogramming
mechanisms (Hanna et al., 2009; Soldner et al., 2009;
Yamanaka, 2009). For instance, the Dox system has been
used to demonstrate that reprogramming somatic cells to
iPSCs occurs in a sequential and stochastic manner (Hanna
et al., 2009; Yamanaka, 2009). However, limitations of the
Dox system, such as the need for a transactivating protein
as well as limited control of gene expression levels (Gossen
et al., 1995), clearly demonstrate the need for a more flex-
ible system with fine-tuning capabilities to further dissect
the molecular mechanisms of reprogramming. By deter-
mining the optimal levels of reprogramming factors neces-
sary, we may be able to improve the efficiency and quality
of reprogramming in multiple species in which reprogram-
ming remains elusive.
Recently, an inducible system to regulate protein stability
by a commercially available small molecule, trimethoprim
(TMP), was reported (Iwamoto et al., 2010; Sando et al.,
2013). In this system, protein instability is conferred by en-
gineering a fusion protein with the destabilizing domain
(dd) derived from Escherichia coli dihydrofolate reductase,Stewhich targets the fusion protein to the proteasome for
degradation (Iwamoto et al., 2010). The addition of TMP
stabilizes the fusion protein in a rapid, reversible, and
dose-dependentmanner, thereby altering the protein-turn-
over rate to transform a short-lived or nondetectable pro-
tein into a protein that functions for a precisely controlled
period of time (Iwamoto et al., 2010).
Wehave incorporated the TMP-regulated dd into piggyBac
transposon-based reprogramming vectors to allow induc-
ible generation of mouse and pig iPSCs. We are able to
fine-tune the level and duration of reprogramming protein
stability and analyze the stoichiometry and temporal re-
quirements in detail. A recent report that used single-cell
expression analyses revealed the essential role of SOX2 dur-
ing the late phase of reprogramming (Buganim et al., 2012).
By using the TMP system, we further found that Sox2 is also
essential during early andmiddle phases of reprogramming.RESULTS
Reprogramming of Mouse Fibroblasts with the
TMP-Inducible System
To create the TMP-inducible reprogramming system, we
constructed two piggyBac transposon overexpression vec-
tors, OddKS and OKS (Figure 1A; Table S1 available online),
both of which encode the human OCT4, KLF4, and SOX2
(hOCT4, hKLF4, and hSOX2) cDNA sequences as a single
open reading frame linked by the F2A and T2A sequences,
respectively (Okita et al., 2008; Szymczak et al., 2004). Them Cell Reports j Vol. 2 j 721–733 j May 6, 2014 j ª2014 The Authors 721
Figure 1. Generation of Mouse iPSCs by a TMP-Inducible piggyBac Vector
(A) Schematic representation of the piggyBac transposon reprogramming vectors. Three factors, hOCT4, hKLF4, and hSOX2, linked by 2A
peptides, were coexpressed and driven by the constitutively active EF1a promoter. The destabilizing domain (dd) was fused to the 50 end of
the hOCT4 gene in the OddKS vector. The OKS vector with unfused hOCT4 was used as the control. SV40E pA, the SV40 early polyadenylation
signal; PB30 and PB50, terminals of the piggyBac transposon.
(legend continued on next page)
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TMP-Inducible Reprogramming Systemdestabilizingdomain (dd)wasencoded in frameat the50 end
of the OCT4 cDNA in the OddKS construct and represented
the only difference between the two constructs. These con-
structswere individually introducedby electroporation into
Oct4-GFPmouse embryonic fibroblasts (MEFs) that carried a
transgene composed of the 18 kb Oct4 promoter sequence
upstream of the GFP coding sequence. OddKS -transfected
fibroblasts were grown in the absence of TMP or in 1 mM
TMP. By day 6 posttransfection, colonies with an ESC-like
morphology started to appear among the MEFs transfected
withOKS andOddKS + 1 mMTMP, but not among theOddKS
MEFs without TMP. By day 8, the ESC-like colonies showed
distinct edges, a hallmark of ESC colonies, and were clearly
GFP positive under fluorescence microscope. At day 14,
all of the ESC-like colonies uniformly expressed GFP (Fig-
ure 1B). About 287 ± 23 GFP-positive colonies arose from
7.2 3 104 cells that were transfected with the OddKS vector
and treated with 1 mM TMP, representing a reprogramming
efficiency of0.40%, similar to the efficiency of cells trans-
fected with the OKS control vector, 0.38% (279 ± 26 GFP-
positive colonies per 7.23 104 cells transfected) (Figure 1C;
Table S2). No GFP-positive colonies were detected in the
absence of TMP at day 14 or day 20, when cells became
too confluent to be cultured further. Taken together, these
data demonstrated that our TMP-inducible reprogramming
system is fully TMP dependent, with a clear all-or-none
effect. GFP-positive clones were picked at day 15 and
expanded,which showed similar behavior duringpassaging
as other iPSC lines obtained frommore conventional proto-
cols. These iPSCs have been continuously maintained for
more than 35 passages by standard trypsinization. They
homogenously expressed the stem cell markers OCT4,
NANOG, and SSEA1 (Figure S1). Transplantation of these
cells into nude mice resulted in teratomas that consisted of
tissues derived from all three germ layers, indicating that
these cells are pluripotent (Figure S2).
To follow the dynamics of TMP-regulated OCT4 protein
expression, we monitored exogenous dd-hOCT4 and
endogenous mOCT4 protein levels in transfected MEFs at
six time points covering the three phases of reprogram-
ming: early stage (day 1, 2), middle stage (day 5, 8), and
late stage (day 11, 14). The anti-OCT4 antibody used can(B) Micrographs of iPSCs in the absence or presence of 1 mM TMP 14
regulated stability of OCT4 led to reprogrammed GFP-positive iPS co
treatment; bottom: OKS vector, no TMP treatment. Scale bar, 500 mm
(C) The number of GFP-positive colonies obtained by transposon-bas
electrotransfection. Experiments were performed at least three times
(D) Micrographs of iPSCs in the presence of 1 mM TMP with the OddKS
500 mm.
(E) Western blots of OddKS- and OKS-transfected MEFs monitoring the p
expression at multiple time points in the presence or absence of TM
expression, and G4-56 ES cells were used as the positive control (C+)
Stedetect OCT4 of both mouse and human origin. Mouse
OCT4 has a predicted molecular weight of approximately
43 kDa, whereas hOCT4 has a higher molecular weight
(63.6 kDa) because of the dd addition (20 kDa) to the
N terminus of OCT4 and residual 2A peptide (0.6 kDa)
linked to the C terminus of OCT4.Multiple replicate exper-
iments showed similar protein expression dynamics for
hOCT4 andmOCT4, whichwas consistent with the timing
of colony formation and morphological changes (Figures
1D and 1E). In the TMP induction group or OKS group,
no GFP-positive colonies were observed until day 8
(Figure 1D), which coincided with initial endogenous
mOCT4 detection (Figure 1E). The group without TMP
treatment did not form iPS colonies and showed no detect-
able mOCT4 expression at any time point (Figure 1E). The
RNA levels of hOCT4 and mOct4 at these time points are
shown in Figure S3. Intriguingly, we found that during
reprogramming mRNA levels of hOCT4 did not correlate
with the protein levels. Similarly, in the group of OKS in-
duction, peak hOCT4 RNA levels were seen at day 8 (Fig-
ure S3), whereas the time of peak of protein levels appeared
at day 5 (Figure 1E). These results suggest thatOCT4 expres-
sion is also regulated at the protein level during reprogram-
ming, independent of TMP induction.
In order to compare reprogramming efficiency by
limiting the availability of stable KLF4 or SOX2, we con-
structed three additional vectors, OKddS and OKSdd, which
have the dd fused to the 50 end of hKLF4 or hSOX2, respec-
tively (Figure 2A), and dd-3, where all three genes have
a fused dd domain (Figure 2A). After electroporation into
Oct4-GFP MEFs and treatment with TMP, all three vectors
were competent to give rise to iPSCs, which exhibited
strong alkaline phosphatase activity (Figure 2B). Whereas
OddKS or OKSdd had a reprogramming efficiency compara-
ble to OKS (0.38%), OKddS had a 30% increased efficiency
(0.56%, 402 ± 21 GFP-positive colonies per 7.2 3 104
transfected cells). In contrast, we only obtained 62 ± 3
GFP-positive colonies from 7.2 3 104 cells transfected
with the dd-3 vector, a much lower reprogramming effi-
ciency of 0.08% (Figure 2C). These data demonstrated
that all vectors with a single factor fused to the dd domain
have a similar reprogramming efficiency.days after electroporation with the OddKS or OKS constructs. TMP-
lonies. Top: OddKS, no TMP treatment; middle: OddKS + 1 mM TMP
.
ed reprogramming per 7.2 3 104 cells were scored at day 14 post-
per condition. Error bars, SD.
or OKS constructs at different days after electroporation. Scale bar,
resence of exogenous OCT4 (hOCT4) and endogenous OCT4 (mOCT4)
P. Oct4-GFP MEFs were used as a negative control (C) for OCT4
.
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Figure 2. Comparison of Mouse iPSC Generation by Different TMP-Inducible Vectors
(A) Schematic representation of alternate piggyBac transposon reprogramming vectors. The destabilizing domain (dd) was fused to the 50
end of the KLF4, SOX2, or all three factors (OKddS, OKSdd, and dd-3, respectively).
(B) Micrographs of Oct4-GFP MEFs 14 days after stable transfection, with OddKS, OKddS, OKSdd, and dd-3, treated with 1 mM TMP, or OKS
untreated cells. Scale bar, 500 mm.
(C) The number of GFP-positive colonies obtained following transfection of the various vectors in 7.2 3 104 cells were scored at day 14
after transfection and 1 mM TMP treatment. Experiments were performed at least three times per condition. Error bars, SD.
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TMP-Inducible Reprogramming SystemEffect of TMP Dose and Duration on OCT4 Expression
To characterize in detail the dose dependence of OCT4 pro-
tein stability on the concentration of TMP, we transfected
Oct4-GFP MEFs with the OddKS or control OKS vector and
treated with various concentrations of TMP for 5 days. As
determined by qRT-PCR, RNA levels of dd-hOCT4 from
each group were very similar (Figure 3A), whereas protein724 Stem Cell Reports j Vol. 2 j 721–733 j May 6, 2014 j ª2014 The Authorslevels increased in a dose-dependent manner as measured
bywestern blot (Figures 3B and 3C). Treatmentwith as little
as 10 nM TMP was able to confer significant protein stabil-
ity, and the entire pool of dd-hOCT4 could be stabilized by
1 mM TMP (Figures 3B and 3C).
To determine if the dd-hOCT4 stability is dependent
on the continued presence of TMP, we analyzed stabilized
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Figure 3. Characterization of TMP-
Dependent Protein Stability
(A) OddKS-transfected Oct4-GFP MEFs were
treated with varying concentrations of TMP
for 5 days and analyzed by quantitative PCR
(qPCR) for hOCT4 RNA levels. For compari-
son, the RNA level of hOCT4 with 10 mM TMP
treatment was arbitrarily set to one. Oct4-
GFP MEFs were used as a negative control,
and OKS was used as the positive control.
(B) Western blot analysis of dd-hOCT4
protein 5 days after TMP exposure. Mouse
GAPDH acted as a loading control. Oct4-
GFP MEFs were used as the negative con-
trol (C).
(C) The protein levels of dd-hOCT4 at day 5
were quantified using Gelpro32 software,
and the indicated ratios normalized against
the dd-hOCT4 protein levels seen when cells
were treated with 10 mM TMP treatment
cells are graphed.
(D) OddKS-transfected Oct4-GFP MEFs were
exposed to 1 mM TMP for 5 days and then
TMP was withdrawn from a subset of plates.
Western blot analysis for dd-hOCT4 protein
was performed at the indicated time points
under continued TMP exposure or following
withdrawal. Oct4-GFP MEFs were used as the
negative control (C).
(E) The levels of dd-hOCT4 protein from (D)
were quantified using Gelpro32 software,
and the indicated ratios were graphed.
Data in (A), (C), and (E) indicate the
means ± SD of three independent experi-
ments.
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TMP-Inducible Reprogramming Systemprotein levels after TMP removal. Because OddKS-trans-
fected Oct4-GFP MEFs showed that dd-hOCT4 stability
was maximized at day 5 after 1 mM TMP treatment (Fig-
ure 1E), we repeated this experiment and analyzed protein
levels following TMP removal. As little as 4 hr after TMP
was removed from the medium, dd-hOCT4 protein level
decreased by more than 95% (Figures 3D and 3E). In
summary, TMP-mediated dd-hOCT4 stability strongly
correlated with TMP dosage and dd-hOCT4 was rapidly
degraded following TMP withdrawal.
Stoichiometry and Temporal Requirement of
Reprogramming Factors
Because dd-hOCT4 stability was dependent on TMP
dosage, we set out to determine if its reprogramming
function is also under the same dosage constraints. There-
fore, we treated OddKS-transfected Oct4-GFP MEFs with
different concentrations of TMP (1 nM, 10 nM, 100 nM,Ste1 mM, and 10 mM) and scored GFP-positive colonies at
day 14. TMP concentration of 1 or 10 nM was not suffi-
cient to reach the same reprogramming efficiency as the
OKS construct lacking the destabilizing domain, and
only a few iPS clones were induced (Figure 4A). As TMP
concentration increased, both protein levels and the
number of GFP-expressing colonies increased (Figures
4A–4C). The lowest concentration of TMP capable of
reaching the maximum reprogramming efficiency of
0.40%, was 100 nM (0.38%; 45 ± 6 GFP-positive col-
onies per 1.2 3 104 transfected cells). Furthermore, total
OCT4 protein expression level in these reprogrammed
colonies was not significantly different from blastocyst-
derived mouse G4 ES cells (Figures 4A–4C). Although
TMP does not regulate dd-hOCT4 at the mRNA level,
the dd-hOCT4 mRNA expression appeared to increase
along with the increase of TMP concentration (Fig-
ure 4D). Because higher TMP produces more iPS colonies,m Cell Reports j Vol. 2 j 721–733 j May 6, 2014 j ª2014 The Authors 725
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Figure 4. Stoichiometry and Temporal
Requirement of Protein Expression of
Classic Reprogramming Factors
(A) OddKS-transfected Oct4-GFP MEFs were
treated with varying concentrations of TMP
for 14 days. The number of GFP-positive
colonies obtained by transposon-based re-
programming per 1.2 3 104 cells were
scored at day 14 posttransfection. Experi-
ments were performed three times for each
condition. Error bars, SD.
(B) Western blot analysis of dd-hOCT4 and
mOCT4 protein at day 14. Mouse GAPDH was
used as a loading control. Oct4-GFP MEFs
were used as a negative control (C). G4
mouse ES cells were used as a positive
control (C+).
(C) The levels of total OCT4 protein at day 14
were quantified using Gelpro32 software,
and the indicated ratios normalized against
the OCT4 protein expression levels of G4-56
mouse ES cells are plotted. Data indicate
the means ± SD of three independent
experiments.
(D) qPCR analysis of dd-hOCT4 RNA at
day 14. The RNA level of dd-hOCT4 in the
transfected cells with 0 nM TMP treatment
was set to one. Oct4-GFP MEFs were used as
a negative control. Data indicate the means
± SD of three independent experiments.
(E) OddKS-, OKddS-, or OKSdd-transfected
Oct4-GFP MEFs were treated with 1 mM TMP
during the varying time periods indicated.
The number of GFP-positive colonies ob-
tained by transposon-based reprogramming
per 1.2 3 104 cells were scored at day 14
and day 20 postelectrotransfection. Exper-
iments were performed at least three times
per condition. Error bars, SD.
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Figure 5. Regulation of DNA Demethylation-Related Factors
during Reprogramming
(A) Schematic representation of piggyBac transposon reprogram-
ming vectors. Each factor was fused with dd, and expression was
driven by the constitutively active EF1a promoter.
(B) The Oct4-GFP MEFs were transfected with the varying TMP-
inducible vectors indicated to generate mouse iPSCs. The number of
GFP-positive colonies obtained per 7.2 3 104 cells were scored at
day 14 posttransfection. Experiments were performed at least three
times per condition. Error bars, SD.
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TMP-Inducible Reprogramming Systemdd-hOCT4 mRNA would make up a greater proportion of
the total RNA.
Previously it was reported that continuous ectopic
expression of OCT4 and KLF4 is required for at least
12 days with the Dox system. Ectopic SOX2 expression
for only 5 days was enough to give rise to AP-positive col-
onies, and prolonged ectopic SOX2 expression greatly
increased the number of AP-positive colonies (Sridharan
et al., 2009). However, the Dox system is not versatile
enough to allow for more detailed dissection of temporal
requirements of the four factors. Taking advantage of our
TMP system, we sought to investigate the temporal require-
ment for each of these ectopic factors during reprogram-
ming. Fibroblasts were transfected with OddKS, OKddS, or
OKSdd, and 1 mMTMP treatment was restricted to a specific
phase, or phases, of reprogramming (Figure 4E). Fibroblasts
induced to express dd-hOCT4 for 6 days gave rise to GFP-
positive colonies, and the efficiency of iPSC generation
increased to 0.36% (43 ± 2 colonies per 1.2 3 104 cells
transfected) after treating with TMP for an additional
5 days. No further increase in the number of iPS colonies
was observed, even when dd-hOCT4 was maintained for
longer periods. Interestingly, TMP induction of dd-
hOCT4 for only 3 days during the early stage (days 1–4)
did not generate any iPS colonies, suggesting that at least
6 days of ectopic OCT4 expression was required for iPSCStegeneration. In contrast, only 2 days of TMP addition during
the later phases (days 7–8) was able to give rise to iPSCs,
suggesting that these cells had been in a partially reprog-
rammed state. When culture was maintained for 20 days,
we found that TMP induction of dd-hOCT4 at the late stage
could generate iPSCs at frequencies comparable to TMP in-
duction at the early stage (Figure 4E).
Similar to dd-hOCT4, dd-hKLF4 induction, for any
period tested, was able to effectively reprogram MEFs,
and comparable efficiency could be reached with similar
TMP treatment regimens. In contrast to the result obtained
with dd-hOCT4, ectopic KLF4 expression for only 3 days
during the early stage (days 1–4) was able to generate
GFP-positive iPSCs (Figure 4E). When OKSdd was
examined, surprisingly, we found that exogenous SOX2
expression from day 4 to day 8 was most important for
iPSC induction. dd-hSOX2 induction from day 1 to day 3
failed to generate GFP positive colonies, as did induction
on or after day 9. These results indicated that hSOX2
mainly acted at the early stage (day 1–4) and middle stage
(days 5–8) of reprogramming, whereas exogenous SOX2
expression during the late stage only (days 9–14) was inef-
fective in iPSC generation. Taken together, these data
demonstrated a different temporal requirement for each
ectopic factor. Treatment with exogenous OCT4 and exog-
enous KLF4 during any reprogramming phase had the
potential to generate iPSCs (Figure 4E), which is consistent
with experiments reported by others (Hanna et al., 2009).
However, exogenous SOX2 expression was required at the
early stage (days 1–4) and middle stage (days 5–8) of
reprogramming.
Regulation of Other Factors during Reprogramming
We next asked whether our TMP system could be extended
to test other factors during reprogramming. Previous
research suggested that reprogramming of somatic cells is
accompanied by global epigenetic remodeling, including
DNA demethylation (Cowan et al., 2005; Maherali et al.,
2007; Tada et al., 2001). However, the effect of ectopic
expression of DNA demethylation factors during iPSC
generation was not well documented. We constructed
four vectors in which dd was fused to the 50 end of the
genes involved in DNA demethylation, including human
growth arrest and DNA-damage-inducible protein 45 alpha
(hGADD45a) (Barreto et al., 2007), human methyl-CpG-
binding domain (hMBD4) (Bhattacharya et al., 1999), hu-
man thymine DNA glycosylase (hTDG) (Maiti and Drohat,
2011), and human activation induced cytidine deaminase
(hAID) (Morgan et al., 2004; Rai et al., 2008), to investigate
the temporal requirements for the four demethylation fac-
tors on reprogramming efficiency (Figure 5A). Oct4-GFP
MEFs were cotransfected with OKS and dd-Factor mixed
with PBase. TMP treatment was applied at different timem Cell Reports j Vol. 2 j 721–733 j May 6, 2014 j ª2014 The Authors 727
Figure 6. Generation of Pig iPSCs by TMP-
Inducible Vector OddKSM
(A) Schematic representation of the
piggyBac transposon reprogramming vec-
tors. Four coexpressed factors, hOCT4,
hKLF4, hSOX2, and hc-MYC, were linked by
2A peptides and driven by the constitu-
tively active EF1a promoter. The destabi-
lizing domain (dd) was fused to the 50 end
of the OCT4 gene, and this plasmid is
designated OddKSM.
(B) A representative primary colony formed
at day 9 of pig iPSC induction using the
TMP-inducible vector.
(C) Pig iPSCs in 2i medium showed stably
compacted colony with continuously added
TMP.
(D) Pig iPSCs in 2i medium without TMP for
3 days lost compacted colony morphology
and differentiated.
(E) Pig iPSCs in 2i medium with TMP main-
tained compacted colony morphology in
further culture. Scale bar, 500 mm.
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TMP-Inducible Reprogramming Systempoints and for various time periods. Interestingly, our
results indicated that addition of these four factors did
not improve reprogramming efficiency, no matter when
these factors were added by TMP induction (Figure 5B).
This result is opposite to the expectation that demethyla-
tion factors might enhance reprogramming. However, it
complements a recent report that knockdown of another
demethylation factor MBD3 increases reprogramming effi-
ciency (Brumbaugh and Hochedlinger, 2013).
Application of TMP Reprogramming System in Other
Species
To test whether the TMP reprogramming system could be
used in species other than the mouse, we reprogrammed
pig embryonic fibroblasts with TMP-inducible vector
OddKSM, where hOCT4 could be regulated by TMP. The
four reprogramming genes on the vector (dd-hOCT4,
hKLF4, hSOX2, and hc-MYC) were connected by F2A,
T2A, and F2A (Figure 6A). TMP was added to the culture
medium throughout the entire reprogramming process.
Six days after transfection, primary iPS colonies appeared,
with morphology similar to mouse ESC colonies (Fig-
ure 6B). At day 14, we picked individual colonies and
transferred them to dual inhibition (PD0325901 plus
CHIR99021) (2i) medium (Ying et al., 2008) supplemented
with TMP (Figure 6C), and they could be passaged by stan-
dard trypsinization >30 times without any sign of deterio-
ration. To test the dependence of established iPSC lines on728 Stem Cell Reports j Vol. 2 j 721–733 j May 6, 2014 j ª2014 The Authorsexogenous dd-hOCT4 stabilization, TMP was removed
from the culture media. Upon TMP removal, pig iPSCs
lost their domed colony morphology and differentiated
(Figure 6D), in contrast to the same iPSC lines cultured in
2i medium with TMP (Figure 6E). Although RNA expres-
sion levels of pig iPSCs cultured with and without TMP
were similar, protein levels were markedly altered. Further-
more, pig iPSC lines cultured with TMP were AP+ and
OCT4+, but in the absence of TMP they lost most of the
AP staining and were OCT4 (Figures 7A–7D). This was
consistent with previous observations that maintenance
of pig iPSCs is dependent on exogenous OCT4 (Ezashi
et al., 2009; Fan et al., 2013; Esteban et al., 2009; Wu
et al., 2009).DISCUSSION
In this study, we used a TMP-inducible reprogramming sys-
tem to regulate gene expression at the protein level. This
was a convenient and effective system for controlling the
temporal expression and stoichiometry of reprogramming
factors.
Among different methods, the Dox-inducible system has
been widely used to dissect reprogramming mechanisms
(Hanna et al., 2009; Maherali et al., 2008; Wernig et al.,
2008a). However, Dox-inducible systems have limitations,
such as leaky expression and requirement of additional
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Figure 7. Characterization of the Effect
of TMP Treatment on Pig iPSCs
(A) Quantitative PCR analysis of dd-hOCT4
RNA. For comparison, the RNA level of
hOCT4 in pig iPSCs with no TMP treatment
was arbitrarily set to one. Data indicate the
means ± SD of three independent experi-
ments. Pig embryonic fibroblasts were used
as a negative control.
(B) Western blot analysis of dd-hOCT4
and pOCT4 protein. Pig GAPDH was used as
a loading control.
(C) AP staining of pig iPSC lines cultured
with 1 mM TMP or no TMP. Scale bar, 500 mm.
(D) Immunofluorescent analysis of pig iPSC
lines cultured with 1 mM TMP or no TMP.
Scale bar, 500 mm.
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signed to directly regulate protein stability, instead of regu-
lating expression at the RNA level (Iwamoto et al., 2010).
By adding a small molecule drug TMP, proteins fused to
the dd domain are shielded from degradation. As a bacte-
riostatic antibiotic, TMP is mainly used in the prophylaxis
and treatment of urinary tract infections and can pass the
blood-brain barrier (Barling and Selkon, 1978) and the
placental barrier (Schulz, 1972). No adverse effects have
been observed, even when doses twice the concentration
used to regulate transgenes (0.4 mg/ml; 3 mM) are given
for 6 weeks in vivo (Iwamoto et al., 2010). Furthermore,
compared with a Dox-inducible system, the TMP-inducible
system has several additional advantages. First, the TMP
system is more convenient and does not require additionalStemolecular control components, allowing for direct applica-
tion in various species and cell lines. Second, the levels of
dd fusion proteins increase in a strict dose-dependent
manner (Figures 3B and 3C). Third, the TMP system is high-
ly sensitive; a dose as low as 10 nM TMP is able to induce
protein expression, whereas 1 mMof TMP can fully stabilize
dd fused proteins (Figures 3B and 3C). Four hours after TMP
removal, protein levels quickly fall to undetectable levels
(Figures 3D and 3E).
To date, the derivation and maintenance of high-quality
pig iPSCs that have reproducible chimera formation ability
or germline competency have not been achieved. Pig iPSCs
generated with retroviruses/lentiviruses maintain expres-
sion of exogenous genes and depend on the expression
of exogenous factors to maintain pluripotency, suggestingm Cell Reports j Vol. 2 j 721–733 j May 6, 2014 j ª2014 The Authors 729
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iPSCs are more like epiblast-derived stem cells. This has
been confirmed by several groups including ourselves (Eza-
shi et al., 2009; Fan et al., 2013; Esteban et al., 2009; Wu
et al., 2009). Byuse ofTMP to temporally control exogenous
OCT4 stability, we found that, consistent with previous
reports, pig iPSCs derived by our piggyBac vectors contain-
ing OSKM factors were also incompletely reprogrammed
and needed exo-OCT4 to sustain an undifferentiated
morphology in 2i medium. When expression of exo-
OCT4 was terminated by removing TMP, these pig iPSCs
could no longer maintain pluripotency. By regulation of
exogenous protein stability, the TMP-inducible system
may provide a useful method for the design of screening
strategies to identify factors, chemicals, or small hairpin
RNA inhibitors that could rescue the iPSCs when TMP is
not present. We hope that this may help solve the problem
of incomplete reprogramming of pig iPSCs in the future.
Recent studies show that changes in mRNA levels do
not always correlate with the amount of protein produced
in ESCs (Lu et al., 2009; Thomson et al., 2011). Similarly, we
observed that OCT4 protein levels during reprogramming
do not always correlate with mRNA levels (Figure 1E and
S3). These results emphasize the importance of under-
standing the regulation of genes at the protein level during
reprogramming. At the same time, there is increasing evi-
dence that core transcription factors in ESCs, OCT4 (Liao
and Jin, 2010), SOX2 (Van Hoof et al., 2009), NANOG
(Ramakrishna et al., 2011), KLF4 (Kim et al., 2012), and
c-MYC (Gregory and Hann, 2000) undergo posttransla-
tional modifications, including phosphorylation (Kim
et al., 2012; Van Hoof et al., 2009), sumoylation (Wei
et al., 2007), and ubiquitination (Gregory and Hann,
2000; Liao and Jin, 2010). Recent studies have identified
that ligases and deubiquitinases of UPSmembers are essen-
tial for both ESC self-renewal and differentiation (Buckley
et al., 2012). We speculate that, similar to the situation in
ESCs, posttranslational regulation of core factors may also
play a role in iPSC induction. The TMP system has offered
a unique tool to study this phenomenon in detail.
Previous reports have shown that the stoichiometry and
temporal requirements of reprogramming factors play a
crucial role in determining the epigenetic and pluripotent
state of iPSCs, as well as in determining reprogramming
efficiency (Carey et al., 2011; Nagamatsu et al., 2012; Tie-
mann et al., 2011; Xu et al., 2008). However, the results
from different groups often vary. The cause for this discrep-
ancymay be due to two limitations of viral systems: hetero-
geneous expression (Wernig et al., 2008a) and autoimmune
regulation (Lee et al., 2012). Perhaps these systems used
do not reflect the true status of factor gene expression (Lu
et al., 2009). Here, we report the direct correlation of
OCT4 protein levels and efficiency of iPSC generation,730 Stem Cell Reports j Vol. 2 j 721–733 j May 6, 2014 j ª2014 The Authorsand provide an inducible system to investigate the dy-
namicmolecularmechanism of reprogramming.We found
that exogenous SOX2 expression in the early stage (day
1–4) and middle stage (day 5–8) was essential for reprog-
ramming. The absence of exogenous SOX2 expression
during the early and middle stages cannot be rescued by
exogenous SOX2 expression at the late stage (day 9–14).
Whereas a recent report emphases the upstream role of
endogenous SOX2 in the gene expression hierarchy in
the late phase (Buganim et al., 2012), our functional data
further reveal the essential role of SOX2 during the initial
stages of reprogramming. We propose that reprogramming
is a deterministic process, although in the early stages it ap-
pears to be stochastic. The TMP system is a useful platform
for interrogating reprogramming mechanisms and deter-
mining how individual factors contribute to the reprog-
ramming process. The versatility of the TMP system allows
testing multiple factors simultaneously. This should open
up more uses of the TMP system to study detailed mecha-
nismof factor interactions. In the current study, we focused
on characterizing the temporal requirement of individual
OSK factors. For future studies, detailed interactions should
be further characterized.
In summary, we have shown that the TMP-inducible sys-
tem could be used for efficient iPSC generation. This system
regulates ectopic protein stabilization in a convenient,
highly sensitive, and dose-dependent manner. It provides
a simple and practical tool for research into reprogramming
mechanisms and a potential way to generate safer iPSCs.
This system may be combined with the Dox-inducible sys-
tem to allow for tighter and more precise control at both
mRNA and protein levels.EXPERIMENTAL PROCEDURES
Plasmid Construction
Wefirst synthesized a human codon-optimized gene that codes for
the destabilizing domain (dd) derived from Escherichia coli dihy-
drofolate reductase, with the R12Yand Y100I mutations (Iwamoto
et al., 2010). Fusion PCR was used to construct all of the dd-con-
taining plasmids onto a piggyBac transposon vector backbone
that contains the PB 50 and 30 terminals from the ZGs vector (Wu
et al., 2007). The destabilizing domain (dd) was fused to the N-ter-
minal of the genes used in the study. The EF1a promoter was
placed upstream of the single open reading frame. The OKS genes
with or without related dd sequences were linked with the 2A
sequences by PCR. The CAG promoter-driven PBase was from
the CAG-PBase vector.
Cell Culture
MEFs were isolated from 13.5 days postcoitum. F1 embryos (50%
C57BL/6 and 50% 129sv) from homozygous Oct4-GFP mice
(JaxMice strain name: B6;CBA-Tg(Pou5f1-EGFP)2Mnn/J; stock
number 004654) crossed to 129sv and cultured in Dulbecco’s
Stem Cell Reports
TMP-Inducible Reprogramming Systemmodified Eagle’s medium (DMEM) (Invitrogen) containing 15%
FBS (Invitrogen), 0.5 mM GlutaMAX, 1 3 nonessential amino
acid, and 1 mM Sodium Pyruvate. A germline-competent mouse
ESC line, G4, was cultured in DMEM (Invitrogen) containing
20% FBS (Invitrogen, catalog no. 16141, lot. 821754), 0.5 mM
GlutaMAX, 1 3 nonessential amino acid, 1 mM Sodium Pyruvate,
0.1 mM 2-mercaptoethanol, and 500 U/ml LIF (Millipore). Mouse
iPSC lines were cultured on b2 feeder layers that were 40 Gy 60Co
g-ray treated. Pig iPSC lines were cultured on b2 feeder layers in
the 2i medium as described previously (Ying et al., 2008).
Reprogramming of MEFs Using piggyBac Vectors
On the first day (day 0), MEFs were transfected with various
piggyBac vector combinations, using the Amaxa Basic Nucleofec-
tor Kit for primary mammalian fibroblasts (Lonza), in accordance
with the manufacturer’s instructions. The piggyBac vectors
(pEF1a-OddKS, pEF1a-OKddS, pEF1a-OKSdd, pEF1a-OddKddSdd,
named OddKS, OKddS, OKSdd, and dd-3, respectively) were com-
bined with CAG-PBase plasmid in a 3:1 ratio, 1.5 mg piggyBac vec-
tors, 0.5 mg PBase, per 106 cells. Posttransfected cells were seeded
onto feeder layers. After 24 hr, MEF medium was replaced by ES
mediumwith 350 mg/ml G418 for 5 days. Different concentrations
of TMP were added to test groups from the first day. The medium
was refreshed every day. On day 6, medium was changed to ESC
medium without G418. On day 14, colonies were either counted
by GFP-positive numbers and stained by alkaline phosphatase or
picked and further expanded.
AP Staining
iPSCs were fixed in 4% PFA for 30 min and then washed with PBS
three times, followed by the addition of BM purple (Roche).
Assay for Teratoma Formation
For teratoma formation, three mouse iPSC lines (derived with
OddKS, OKddS, and OKSdd separately, passage 10) were cultured
with ES medium on b2 feeder layers for 2 days (60% to 70%
confluent). Approximately 1 3 106 iPSCs were resuspended in
PBS and injected subcutaneously into nude mice. All three iPSc
lines injected formed tumors within 4 weeks after initial transduc-
tion, and paraffin sections were stained with hematoxylin and
eosin for all histological determinations. Control mice injected
with 1 3 106 b2 feeder cells failed to form teratomas.
Western Blot Analysis
Transfected cells were washed with PBS, and each well was har-
vested and suspended in cell lysis buffer for western blot analysis
at the different indicated times. The concentrations of total cell
protein were measured. Ten micrograms of each lysate sample
was boiled at 95C–100C for 5 min in sample buffer, and proteins
were separated by10% SDS-PAGE and transferred onto polyvinyli-
dene fluoride membrane (GE Healthcare). Nonspecific reactivity
was blocked in 5% nonfat dry milk in Tris-buffered saline and
Tween 20 (1 mM Tris-HCl [pH = 7.5], 150 mM NaCl, and 0.05%
Tween-20) for 1 hr at room temperature. The specific proteins
were analyzed using anti-OCT4 (1:1,000, rabbit monoclonal,
ab109187, abcam), anti-OCT4 (1:3,000, rabbit polyclonal,
ab19857, abcam), or anti-mGAPDH (1:2,000, rabbit monoclonal,Ste#2118, CST). The membranes were washed five times and incu-
bated with goat anti-rabbit IgG HRP (1:20,000) for 1 hr at room
temperature. The membranes were washed again as before and
incubated with substrates that were prepared in accordance with
the manufacturer’s instructions. Each membrane was exposed to
X-ray film for 30 s to 5 min.
qRT-PCR Analysis
Total mRNA was extracted using Trizol reagent (Invitrogen). Total
RNA (2 mg) was reverse transcribed to cDNA using a QuantiTect
Reverse Transcription Kit (205213, QIAGEN), in accordance
with the manufacturer’s protocol. qRT-PCR was performed using
TaqMan Gene Expression Master Mix (Applied Biosystems) on
the ABI7900HT sequence detector (Applied Biosystems). Primer
and probe sequences used in qRT-PCR are as follows:
hOCT4-Forward primer: 50-AGTCGGGGTGGAGAGCAAC-30;
hOCT4-Reverse primer: 50-GGCAAATTGCTCGAGTTCTTTC-30
hOCT4-BHQ-probe: 50-CCCTGCACCGTCACCCCTGG-30
mOct4-Forward primer: 50-AGGCAGGAGCACGAGTGG-30
mOct4-Reverse primer: 50-GGACTCCTCGGGAGTTGGTT-30
mOct4-BHQ-probe: 50-CTGTGCCGACCGCCCCAATG-30
Total-Oct4-Forward primer: 50-CCTGGGGSCAGAGGAAAG-30 S = G/C
Total-Oct4-Reverse primer: 50-AGCTTGGGCTMGAGAAGGAT-30 M=A/C
Total-Oct4-BHQ-probe: 50-TGCCCTTCTGGCGCCGGTTAC-30
mGAPDH-Forward primer: 50-GCACAGTCAAGGCCGAGAA-30
mGAPDH-Reverse primer: 50-CCTCACCCCATTTGATGTTAGTG-30
mGAPDH-BHQ-probe: 50-CATCACCATCTTCCAGGAGCGAGACC-30
pGAPDH-Forward primer: 50-GTCAAGCTCATTTCCTGGTACGA-30
pGAPDH-Reverse primer: 50-GGCCTCTCTCCTCCTCGC-30
pGAPDH-BHQ-probe: 50-CCTCATGGTCCACATGGCCTCCA-30.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and two tables
and can be found with this article online at http://dx.doi.org/10.
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